Target intelligence / Profile preview

Neurokinin receptor (NK receptor)

Target
NK receptor
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Neurokinin receptors, also known as tachykinin receptors, are a family of three G protein-coupled receptors (NK1, NK2, and NK3) that mediate the biological effects of tachykinin neuropeptides such as Substance P, Neurokinin A, and Neurokinin B. These receptors are widely distributed throughout the central and peripheral nervous systems, where they play critical roles in pain transmission, inflammation, smooth muscle contraction, and the regulation of the hypothalamic-pituitary-gonadal axis. NK1 receptors are primarily involved in the emetic reflex and pain perception, making them key targets for antiemetic drugs like aprepitant used in chemotherapy-induced nausea and vomiting. NK2 receptors are predominantly found in the respiratory and gastrointestinal tracts, influencing smooth muscle tone and airway hyperresponsiveness. NK3 receptors have gained significant clinical attention for their role in regulating gonadotropin-releasing hormone (GnRH) secretion, leading to the development of antagonists like fezolinetant for treating menopausal vasomotor symptoms. Therapeutic intervention typically involves small-molecule antagonists designed to block the binding of endogenous ligands, thereby alleviating symptoms associated with overactive tachykinin signaling.

Other names
Tachykinin receptorNK1 receptorNK2 receptorNK3 receptorSubstance P receptorNeurokinin 1 receptorNeurokinin 2 receptorNeurokinin 3 receptorTACR1TACR2TACR3Neurokinin receptors
02

Mechanism of action

Competitive antagonism of tachykinin neuropeptides (Substance P, Neurokinin A, and Neurokinin B) at their respective G protein-coupled receptors, inhibiting downstream signaling pathways involved in emesis, pain, and endocrine regulation.

03

Biological functions

Signal transductionNeurotransmissionInflammationSmooth muscle contractionVasodilationPain processingRegulation of the hypothalamic-pituitary-gonadal axis
04

Disease associations

InflammationNausea and vomitingMenopausal vasomotor symptomsDepressionAnxietyAsthmaIrritable bowel syndromeChronic cough
05

Safety considerations

CYP3A4 drug-drug interactionsFatigueDizzinessLiver enzyme elevationsHeadacheNausea
06

Interacting drugs

8 more in the full profile.

07

Biomarkers

Substance P levelsNeurokinin B levelsLuteinizing hormone (LH) levelsFollicle-stimulating hormone (FSH) levels

Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on Neurokinin receptor (NK receptor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurokinin receptor (NK receptor).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call